课题基金 / 基金详情

SOUTHWEST ONCOLOGY GROUP

SOUTHWEST ONCOLOGY GROUP
西南肿瘤集团
批准号:
7363699
负责人:
THOMAS Patrick MILLER
金额:
$26.65万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
1978
资助国家:
美国
项目状态:
已结题
起止时间:
1978-01-01 至 2009-12-31
关键词:
ABCB1 geneAcademic Medical CentersAccreditationAcuteAcute Lymphocytic LeukemiaAcute Myelocytic LeukemiaAcute Promyelocytic LeukemiaAddressAdenosquamous carcinomaAdherenceAdjuvantAdjuvant TherapyAdministratorAdultAdverse Drug Experience ReportAdverse eventAffectAftercareAgeAge FactorsAgreementAllogenicAltretamineAmericanAmerican Society of Clinical OncologyAmifostineAncillary StudyAnemiaAngiogenic FactorAnthracycline AntibioticsAnthracyclinesAntibioticsAntibodiesAntibody TherapyAntigensAntineoplastic AgentsApoptosisApplications GrantsAra-CArabiaAreaArizonaArt TherapyArtsAttenuatedAtypical Endometrial HyperplasiasAuthorshipAutologousAutologous TransplantationAwardAwarenessAzotemiaB-Cell LymphomasB-Cell NonHodgkins LymphomaB-LymphocytesBackBasic ScienceBedsBehavioral SciencesBilirubinBioinformaticsBiologicalBiological AssayBiological MarkersBiologyBiometryBiopsyBlast PhaseBleomycin/Cytarabine/Methotrexate/VincristineBloodBlood VesselsBlood specimenBone MarrowBone Marrow Stem Cell TransplantationBone Marrow TransplantationBrain NeoplasmsBreastBreast Cancer Prevention TrialBronchoscopyBudgetsCSF3 geneCalciumCalculiCaliforniaCancer CenterCancer Center Support GrantCancer ControlCancer Control ResearchCancer Information ServiceCancer PatientCancer Prevention TrialCancer Trials Support UnitCancer VaccinesCancer and Leukemia Group BCarboplatinCarboplatin/EtoposideCarboplatin/PaclitaxelCarcinomaCardiacCardiovascular systemCell LineCell ProliferationCell TherapyCell physiologyCell surfaceCellsCervical dysplasiaCervix UteriCervix carcinomaCessation of lifeChairpersonChemopreventionChemotherapy-Oncologic ProcedureChestChildren&aposs Oncology GroupChronic Myeloid LeukemiaCisplatinCisplatin/Dacarbazine/Interferon Alfa/TamoxifenClassificationClinicClinicalClinical Cancer CenterClinical DataClinical ImmunologyClinical ManagementClinical MedicineClinical PharmacologyClinical ProtocolsClinical ResearchClinical Research AssociateClinical ServicesClinical TrialsClinical Trials Cooperative GroupClosureCollaborationsColon CarcinomaColoradoColorectalColorectal CancerCombination ChemotherapyCombined Modality TherapyCommitCommittee MembersCommittee MembershipCommunicationCommunitiesCommunity Clinical Oncology ProgramCommunity OutreachComplementComplexCompound 506U78Comprehensive Cancer CenterConflict (Psychology)ConsentConsent FormsConsultConsultationsContinuous InfusionContinuous Intravenous InfusionCooperative Group ProgramCore FacilityCorrelation StudiesCounselingCoupledCyclin D1CyclinsCyclophosphamideCyclophosphamide/Dexamethasone/Doxorubicin/Verapamil/VincristineCyclosporineCyclosporinsCytarabineCytogeneticsDNADNA AdductionDNA Microarray ChipDNA Microarray formatDNA amplificationDailyDataData AnalysesData QualityDatabasesDaunorubicinDendritic CellsDepo ProveraDetectionDevelopmentDevelopmental Therapeutics ProgramDevicesDexamethasoneDiagnosisDiagnosticDiagnostic Neoplasm StagingDiagnostic ProcedureDiagnostic radiologic examinationDiffuseDiffuse LymphomaDisadvantagedDisciplineDiscipline of Nuclear MedicineDiscipline of obstetricsDiseaseDisease remissionDisorder by SiteDistant MetastasisDivision of Cancer BiologyDoctor of MedicineDoctor of PhilosophyDocumentationDonor personDoseDoxorubicinDoxorubicin Hydrochloride LiposomeDoxorubicin/VinblastineDrug Delivery SystemsDrug KineticsDrug resistanceDysmyelopoietic SyndromesERBB2 geneEarly treatmentEastern Cooperative Oncology GroupEducation and OutreachElderlyElectronicsEligibility DeterminationEmergency SituationEndometrial CarcinomaEndometrial HyperplasiaEndometrial adenocarcinomaEndothelial Growth FactorsEnrollmentEnsureEpidermal Growth Factor ReceptorEpidermal Growth Factor Receptor Tyrosine Kinase InhibitorEpithelialEpithelial ovarian cancerErythrocytesErythropoietinEtoposideEtoposide/MitoxantroneEuropeanEvaluationEventExcisionExerciseExperimental DesignsExtramural ActivitiesFacultyFailureFamilyFamily memberFeasibility StudiesFeedbackFellowship ProgramFibroblast Growth FactorFloorFludarabine/MitoxantroneFluorouracilFocus GroupsFollicular LymphomaFollow-Up StudiesFoundationsFreezingFrozen SectionsFundingFunding ApplicantFutureGastroenterologyGastrointestinal NeoplasmsGelatinase AGelatinase BGene ExpressionGene Expression ProfileGene Expression ProfilingGene TargetingGenerationsGenesGeneticGenetic ResearchGenitourinary systemGermanyGlassGlucocorticoidsGlycoproteinsGoalsGoserelinGrantGrowth FactorGrowth Factor ReceptorsGuidelinesGynecologicGynecologic OncologyGynecologic Oncology GroupGynecologistGynecologyHLA-DR AntigensHeadHead and Neck CancerHead and neck structureHealthHealth ProfessionalHealth SciencesHealthcareHeart-Lung TransplantationHelicobacter pyloriHematologic NeoplasmsHematologyHematopathologyHematopoieticHematopoietic NeoplasmsHigh Dose ChemotherapyHispanicsHistocompatibilityHistocompatibility AntigensHistocompatibility Antigens Class IIHistologicHistologyHodgkin DiseaseHome environmentHomologous TransplantationHospitalsHourHousingHumanHuman PapillomavirusHuman ResourcesHyperplasiaHysterectomyI131 isotopeImageImaging technologyImmuneImmune responseImmunobiologyImmunohistochemistryImmunophenotypingImmunotherapyIn VitroIn complete remissionIncidenceIndividualIndustryInfusion proceduresInpatientsInstitutesInstitutionInterdisciplinary StudyInterferon Alfa-2aInterferon Alfa-2bInterferon Type IIInterferon-alphaInterferonsInterleukin-4Interleukin-6InterleukinsInternal MedicineInternationalInternetInterventionIntraepithelial NeoplasiaIntraoperative MonitoringIntravenousInvestigationInvestigational DrugsIsotretinoinJapanJointsJournalsKi-1 Large-Cell LymphomaL-17M protocolLaboratoriesLaboratory ResearchLaboratory StudyLactate DehydrogenaseLaparotomyLarge Intestine CarcinomaLasersLeadLeadershipLocal TherapyLocalizedLocalized DiseaseLungLymphLymph node excisionLymphatic IrradiationLymphedemaLymphoblastic LeukemiaLymphomaLymphoproliferative DisordersMLH1 geneMS4A1 geneMSH2 geneMagnetic Resonance ImagingMaintenanceMaintenance TherapyMajor Histocompatibility ComplexMalignant - descriptorMalignant Female Reproductive System NeoplasmMalignant NeoplasmsMalignant Pleural MesotheliomaMalignant neoplasm of brainMalignant neoplasm of cervix uteriMalignant neoplasm of esophagusMalignant neoplasm of fallopian tubeMalignant neoplasm of gastrointestinal tractMalignant neoplasm of kidneyMalignant neoplasm of lungMalignant neoplasm of ovaryMalignant neoplasm of pancreasMalignant neoplasm of prostateMammalian OviductsMantle Cell LymphomaManuscriptsMarrowMarshalMaster of Public HealthMatrix MetalloproteinasesMeasurementMediastinoscopyMedicalMedical OncologistMedical OncologyMedical centerMedicineMedroxyprogesterone 17-AcetateMelphalanMembraneMenogarilMentorsMesotheliomaMeta-AnalysisMetastatic MelanomaMexicoMicrodissectionMicrosatellite InstabilityMinorityMinority Outreach ProgramMitoxantroneModalityModelingModificationMolecularMolecular Classification of TumorsMolecular DiagnosisMolecular GeneticsMolecular ProfilingMolecular and Cellular BiologyMonitorMoonMorphologyMorusMulti-Drug ResistanceMulticenter StudiesMultidrug Resistance-Associated ProteinsMultimodal ImagingMultiple MyelomaMyelogenousMyeloid LeukemiaN(delta)-acetylornithine, -isomerN-dodecanoylglutamic acid, -isomer, sodium saltNCI Center for Cancer ResearchNational Cancer InstituteNational Surgical Adjuvant Breast and Bowel ProjectNative AmericansNatureNavelbine ditartrateNeoadjuvant TherapyNeoplasm MetastasisNephrectomyNew AgentsNew MexicoNewly DiagnosedNo Evidence of DiseaseNodalNon-Hodgkin&aposs LymphomaNon-Small-Cell Lung CarcinomaNorth AmericaNumbersNurse PractitionersNursesNursing FacultyNursing ResearchNutritionalObstetrics DepartmentsOcular MelanomaOligonucleotidesOncogene ProteinsOncogenicOncologistOncology GroupOperating Room NursingOperating RoomsOperative Surgical ProceduresOralOrchiectomyOrganOther ResourcesOutcomeOutpatientsOvarianOvarian CarcinomaOvariectomyPTGS2 genePaclitaxelPain managementPaperParamedical PersonnelParticipantPathogenesisPathologistPathologyPathway interactionsPatient AppointmentPatient CarePatient EducationPatient RecruitmentsPatientsPatternPediatric Oncology GroupPelvisPerformancePeripheral Blood Stem CellPeripheral Stem Cell TransplantPeripheral Stem Cell TransplantationPeritonealPersonal SatisfactionPersonsPharmaceutical PreparationsPharmacistsPharmacologyPharmacology and ToxicologyPharmacy facilityPhasePhase I Clinical TrialsPhase II Clinical TrialsPhase III Clinical TrialsPhenotypePhiladelphiaPhysical ChemistryPhysician AssistantsPhysician ExecutivesPhysiciansPhysicsPilot ProjectsPiperPlacebosPlan BPlatinumPlayPleuralPoliciesPoliticsPolymerase Chain ReactionPopulationPopulation StudyPositioning AttributePositron-Emission TomographyPostoperative PeriodPrecancerous ConditionsPrednisonePremenopausePreparationPreventionPrevention ProtocolsPrevention programPreventivePrimary NeoplasmPrincipal InvestigatorPrivate PracticeProceduresProcessProductivityPrognostic FactorProgram DevelopmentProgram Research Project GrantsProgression-Free SurvivalsProliferative IndexProspective StudiesProstateProstate Cancer Prevention TrialProstaticProstatic Intraepithelial NeoplasiasProtein ChemistryProtein OverexpressionProteinsProtocols documentationPublic HealthPublicationsPublished CommentPublishingPurinesPurposeQuality ControlQuality of CareQuinineRSR-13RadiationRadiation OncologyRadiation Therapy Oncology GroupRadiation therapyRadioimmunoconjugateRadiosurgeryRandomizedRandomized Clinical TrialsRandomized Controlled Clinical TrialsRangeRateRavenReceptor Protein-Tyrosine KinasesRecombinantsRecording of previous eventsRecoveryRecruitment ActivityRecurrenceRecurrent diseaseRefractoryRegional CancerRegulationRehabilitation therapyRelapseRemission InductionRenal Cell CarcinomaRenal carcinomaReportingReproduction sporesResearchResearch DesignResearch Ethics CommitteesResearch InfrastructureResearch PersonnelResearch Project GrantsResearch ProposalsResearch SupportResectedResidenciesResidual stateResistanceResourcesRetinoidsRetrospective StudiesReview CommitteeReview LiteratureRiceRiskRisk FactorsRoleRunningRural CommunitySCID MiceSDZ-PSC-833SalmonSamplingScheduleScienceScientistSecond Look SurgerySeleniumSeminomaSeriesSerumServicesSignal TransductionSiteSkin CancerSmokerSocietiesSolidSolid NeoplasmSourceSouthwest Oncology GroupSpecific qualifier valueSpecimenStagingStandards of Weights and MeasuresStem cell transplantStem cellsStomach CarcinomaStrategic PlanningStructureStructure of germinal center of lymph nodeSubgroupSupportive careSurgical OncologySuspension substanceSuspensionsSyndromeSystemSystemic TherapyT-LymphocyteTP53 geneTechniquesTelemedicineTestingTextThalidomideTherapeuticTherapeutic EffectTherapeutic IndexTherapeutic procedureThioredoxinThoracic OncologyThoracic Surgical ProceduresTimeTissue Inhibitor of Metalloproteinase-1Tissue ProcurementsTissuesTopotecanToxic effectToxicologyTransfusionTranslational ResearchTranslationsTransplantationTreatment FailureTreatment ProtocolsTretinoinTriplet Multiple BirthTumor BiologyTumor DebulkingTumor MarkersTumor Suppressor ProteinsUniversitiesUpdateUpper armUrogenital CancerUrologic CancerUrologic SurgeonUrologyUtahVariantVascular Endothelial CellVascular Endothelial Growth Factor ReceptorVascular Endothelial Growth Factor Receptor-1Vascular Endothelial Growth FactorsVerapamilVideoconferencesVideoconferencingVinblastineVinorelbineVinorelbine tartrateVirginiaVisitWaldenstrom MacroglobulinemiaWeekWhole-Body IrradiationWingWolvesWomanWorkWritingX-Ray Computed TomographyY 90 Ibritumomab TiuxetanZD1839 (IRESSA)abstractingadenomaalpha-difluoromethyl-DOPA, -isomeralpha-methylornithine dihydrochloride, -isomerangiogenesisanticancer researchantigeneassay developmentauthorityautocrinebasebeta Globinbevacizumabbleomycin/dacarbazine/doxorubicin/vinblastine protocolcancer carecancer cellcancer imagingcancer preventioncancer research center directorcancer surgerycancer therapycelecoxibcell growthcellular targetingchemosensitizing agentchemotherapycisplatin/etoposide protocolclinical Diagnosiscollegecomputerizedconceptcyclin D2cyclin D3cyclophosphamide/doxorubicin/etoposide/methotrexate/prednisone protocoldaltondaydensitydesigndisorder controldrug developmentdrug discoverydrug testingexperiencefludarabinefollow-upfootgastroesophageal junction adenocarcinomagastrointestinalgene therapygenetic risk assessmentgraft vs host diseasehatchinghigh risk menhistiocytehuman subjectiliumimmunopathologyimplementation researchimprovedindexinginhibitor/antagonistinsightinterdisciplinary collaborationinterestintraepithelialintraperitonealintraperitoneal therapyiodine-131-tositumomabirradiationlarge cell Diffuse non-Hodgkin&aposs lymphomaleukemialeukemia/lymphomaleukemogenesismajor vault proteinmalignant breast neoplasmmalignant stomach neoplasmmedical specialtiesmelanomamembermenmetropolitanmolecular oncologymucosa-associated lymphoid tissue lymphomamultidisciplinarynamed groupneoplasticneoplastic cellneuro-oncologynovelnovel strategiesnovel therapeuticsolder patientoncologyoutcome forecastoutreachoutreach programparacrineperformance status 2peritoneal cancerpilot trialpreventprofessorprogenitorprogesterone 11-hemisuccinate-(2-iodohistamine)prognosticprogramspromoterprospectiveprotocol developmentpurinequality assurancereceptorreceptor expressionrecombinant human erythropoietinrepositoryreproductive functionresearch clinical testingresponserituximabsarcomascientific organizationskin cancer preventionsuccesssymposiumtechnology developmenttirapazaminetositumomabtreatment programtrendtrial comparingtumortumor growthtumor progressiontumorigenicvaccine development

项目摘要

项目成果

THOMAS Patrick MILLER的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Funding is requested to support Arizona Cancer Center (University of Arizona) participation in Southwest Oncology Group (SWOG) cooperative cancer clinical research to improve the treatment of cancer in humans. Specific aims and objectives are: 1. To continue to meet our current scientific leadership and core service commitments including: (a) protocol coordination (multiple studies); (b) disease and discipline committee administration; (c) reference and repository laboratory administration; (d) group quality assurance and quality control. 2. To continue to promote the rapid integration of promising new research leads, including those developed at the Arizona Cancer Center, into cooperative group testing to improve patient treatment options and patient care. 3. To continue to meet our institutional clinical research commitments in the recruitment of appropriate patients for SWOG and SWOG-endorsed studies and all attendant commitments to Iong-term follow-up, quality assurance, quality control, etc. 4. To continue to promote physician and patient awareness of and participation in SWOG and SWOG-endorsed clinical trials and outreach programs. 5. To continue efforts to understand factors affecting accrual, particularly those in special populations (e.g., minority, elderly, financially disadvantaged), and to implement appropriate interventions where possible.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
MEDICAL ONCOLOGY DEVELOPMENT RESEARCH
  • 批准号:
    6236373
  • 项目类别:
  • 资助金额:
    $18.14万
  • 财政年份:
    1996
  • 负责人:
    THOMAS Patrick MILLER
  • 依托单位:
SOUTHWEST ONCOLOGY GROUP CA-13612
  • 批准号:
    6341814
  • 项目类别:
  • 资助金额:
    $42.29万
  • 财政年份:
    1978
  • 负责人:
    THOMAS Patrick MILLER
  • 依托单位:
SOUTHWEST ONCOLOGY GROUP
  • 批准号:
    3556197
  • 项目类别:
  • 资助金额:
    $25.27万
  • 财政年份:
    1978
  • 负责人:
    THOMAS Patrick MILLER
  • 依托单位:
SOUTHWEST ONCOLOGY GROUP
  • 批准号:
    7224242
  • 项目类别:
  • 资助金额:
    $26.64万
  • 财政年份:
    1978
  • 负责人:
    THOMAS Patrick MILLER
  • 依托单位:
海外基金